ESMO 2022 | Highlights from ESMO 2022 in melanoma

Omid Hamid, MD, The Angeles Clinic and Research Institute, Santa Monica, CA, shares his highlights from the European Society for Medical Oncology (ESMO) 2022 Congress in melanoma, particularly in immunotherapy for metastatic melanoma which showed promising data on adoptive T-cell therapies, as well as durable responses with ImmTAC’s. This interview took place at the European Society for Medical Oncology (ESMO) 2022 Congress in Paris, France.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.